Supplementary Table S1 from Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)
Authors:
- Joshua TobiasJTJoshua Tobias
- Marina MaglakelidzeMMMarina Maglakelidze
- Zoran AndrićZAZoran Andrić
- Dinara RyspayevaDRDinara Ryspayeva
- Iurie BulatIBIurie Bulat
- Ivan NikolićINIvan Nikolić
- Zoran PetrovićZPZoran Petrović
- Tanuj ChawlaTCTanuj Chawla
- Rajnish NagarkarRNRajnish Nagarkar
- Erika Garner-SpitzerEGErika Garner-Spitzer
- Christoph C. ZielinskiCZChristoph C. Zielinski
- Leslie Mi Ok ChongLCLeslie Mi Ok Chong
Open Access
- 13 September 2024
- other
- Published by American Association for Cancer Research (AACR)